Ardelyx Inc logo

Ardelyx Inc

ARDX
Healthcare|Biotechnology|USA
$5.28
-0.10 (-1.77%)
Tangible Book
$0.60

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 543.72, 740.18, 985.22, 1271.93, 1446.52 ], "ebit_estimate": [ 13.07, 157.46, 351.07, 579.01, 730.01 ], "ebitda_estimate": [ 12.87, 163.16, 353.13, 468.14, 546.09 ], "net_income_estimate": [ -13.21, 124.5, 298.69, 474.41, 591.99 ], "per_share_eps_estimate": [ -0.05, 0.46, 1.08, 1.79, 2.27 ], "eps_nri_estimate": [ -0.06, 0.48, 1.14, 1.79, 2.27 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -13.44, 148.5, 336.12, 570.41, 717.75 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -15.75, 53.66, 59.91, null, null ], "gross_margin_estimate": [ 95.37, 95.44, 95.6, 95.6, 95 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 11.43, 4.88, 2.95, 2.33 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "34.42", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 34.42, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.74, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 126.77, 149.95, 172.48, 130.13, 170.49, 198.69, 225.95 ], "ebit_estimate": [ -4.14, 14.57, 34.37, -10.24, 25.11, 48.77, 70.78 ], "ebitda_estimate": [ 1.01, 14.63, 25.41, null, null, null, null ], "net_income_estimate": [ -9.39, 8.61, 25, -14.75, 19.16, 41.03, 60.06 ], "per_share_eps_estimate": [ -0.04, 0.04, 0.1, -0.06, 0.08, 0.16, 0.24 ], "eps_nri_estimate": [ -0.04, 0.03, 0.1, -0.07, 0.08, 0.16, 0.24 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -9.15, 8.93, 24.37, -7.99, 26.7, 48.24, 64.32 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -31.04, 7.17, 38.88, null, null, null, null ], "gross_margin_estimate": [ 94.95, 95.55, 95.9, 95, 95, 95, 95 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 182.07, 35.44, 19.06, 12.69, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "34.42", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 34.42, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.74, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-26 19:51:36
2026-06-26 18:56:15
2026-06-16 18:00:21
2026-06-16 17:32:04